07.02.18
Oakland, CA
www.clorox.com
Sales: $2.7 billion for household and institutional cleaning products and personal care products. Corporate sales: $5.9 billion
Key Personnel: Benno Dorer, chairman and chief executive officer; Laura Stein, executive vice president and general counsel; Dawn Willoughby, executive vice president and chief operating officer; Bill Bailey, senior vice president, corporate business development; Diego Barral, senior vice president and general manager, international division; Denise A. Garner, senior vice president and chief innovation officer; Kevin Jacobsen, senior vice president and chief financial officer.
Major Products: Household—Clorox, Formula 409, Liquid-Plumr, Pine Sol and Green Works cleaning products; Personal care—Burt’s Bees, Renew Life digestive health.
New Products: Burt’s Bees—Beauty, Protein Powders and Flavor Crystals lip balms; Clorox—Total 360 System, Scentiva bathroom cleaners, Triple Action bleach (Latin America), Disinfecting Wipes Easy-to-Pull, Healthcare VersaSure wipes; Power Gel, Bleach with ChloroMax.
Comments: Corporate sales rose more than 3% last year, led by gains in the cleaning category, where volume, net sales and earnings from continuing operations before income taxes increased by 10%, 5% and 2%, respectively, during the year. Both volume and net sales growth were driven primarily by higher shipments across several Clorox branded products within home care, primarily Clorox disinfecting wipes and toilet cleaning products due to expanded club distribution and increasing merchandising support, and the new product launch of Scentiva wipes and sprays. There were also higher shipments in professional products, mainly in cleaning products. These increases were partially offset by lower shipments in laundry, primarily due to continued category softness.
Company-wide, sales in the e-commerce channel rose more than 30% last year.
For the nine months ended March 31, 2018, corporate sales rose 2% to more than $4.4 billion, with cleaning product sales up 3% to over $1.5 billion. Earlier this year, Clorox expanded its health and wellness portfolio with the $700 million purchase of Nutranext, a Florida-based, vertically-integrated producer of dietary supplements. As a result, the company has gained a foothold in a market that’s expected to reach $220 billion worldwide by 2022.
There’s sure to be more to come. Clorox markets its bleach, cat litter and personal care products in more than 100 countries, but international stales still only account for 17% of revenue. Outside of North America, Clorox generates the most revenue in Latin America, which accounts for approximately 9% of the top line.
Last month, Clorox Healthcare rolled out VersaSure cleaner disinfectant wipes, which are are EPA-registered to kill 44 pathogens in two minutes or less. The low odor, low residue formula enhances quat activity on surfaces to deliver broader efficacy and faster kill times without co-actives, according to Clorox. The result is a versatile, one-step cleaner disinfectant wipe with the speed and efficacy healthcare facilities rely on and superior aesthetics, wetness and cleaning power needed for convenient, compliant use facility-wide.
For the year, company executives have boosted fiscal 2018 sales growth estimates to 3%, up from 1-3%. The increase is expected to come from Nutranext gains.
www.clorox.com
Sales: $2.7 billion for household and institutional cleaning products and personal care products. Corporate sales: $5.9 billion
Key Personnel: Benno Dorer, chairman and chief executive officer; Laura Stein, executive vice president and general counsel; Dawn Willoughby, executive vice president and chief operating officer; Bill Bailey, senior vice president, corporate business development; Diego Barral, senior vice president and general manager, international division; Denise A. Garner, senior vice president and chief innovation officer; Kevin Jacobsen, senior vice president and chief financial officer.
Major Products: Household—Clorox, Formula 409, Liquid-Plumr, Pine Sol and Green Works cleaning products; Personal care—Burt’s Bees, Renew Life digestive health.
New Products: Burt’s Bees—Beauty, Protein Powders and Flavor Crystals lip balms; Clorox—Total 360 System, Scentiva bathroom cleaners, Triple Action bleach (Latin America), Disinfecting Wipes Easy-to-Pull, Healthcare VersaSure wipes; Power Gel, Bleach with ChloroMax.
Comments: Corporate sales rose more than 3% last year, led by gains in the cleaning category, where volume, net sales and earnings from continuing operations before income taxes increased by 10%, 5% and 2%, respectively, during the year. Both volume and net sales growth were driven primarily by higher shipments across several Clorox branded products within home care, primarily Clorox disinfecting wipes and toilet cleaning products due to expanded club distribution and increasing merchandising support, and the new product launch of Scentiva wipes and sprays. There were also higher shipments in professional products, mainly in cleaning products. These increases were partially offset by lower shipments in laundry, primarily due to continued category softness.
Company-wide, sales in the e-commerce channel rose more than 30% last year.
For the nine months ended March 31, 2018, corporate sales rose 2% to more than $4.4 billion, with cleaning product sales up 3% to over $1.5 billion. Earlier this year, Clorox expanded its health and wellness portfolio with the $700 million purchase of Nutranext, a Florida-based, vertically-integrated producer of dietary supplements. As a result, the company has gained a foothold in a market that’s expected to reach $220 billion worldwide by 2022.
There’s sure to be more to come. Clorox markets its bleach, cat litter and personal care products in more than 100 countries, but international stales still only account for 17% of revenue. Outside of North America, Clorox generates the most revenue in Latin America, which accounts for approximately 9% of the top line.
Last month, Clorox Healthcare rolled out VersaSure cleaner disinfectant wipes, which are are EPA-registered to kill 44 pathogens in two minutes or less. The low odor, low residue formula enhances quat activity on surfaces to deliver broader efficacy and faster kill times without co-actives, according to Clorox. The result is a versatile, one-step cleaner disinfectant wipe with the speed and efficacy healthcare facilities rely on and superior aesthetics, wetness and cleaning power needed for convenient, compliant use facility-wide.
For the year, company executives have boosted fiscal 2018 sales growth estimates to 3%, up from 1-3%. The increase is expected to come from Nutranext gains.
